Leaders in Research Peptides

(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD

GDF-8 (Myostatin)

£88.19£97.17

Buy GDF-8 Myostatin 1mg Peptide Vial

GDF-8, also known as Myostatin, is a peptide that plays a crucial role in regulating muscle growth in mammals. It’s a protein produced and released by myocytes that acts on the muscle cells to inhibit myogenesis: muscle cell growth and differentiation. In other words, Myostatin acts as a biological brake on muscle development and strength, and its inhibition or mutation can lead to significant increase in muscle mass and power.

 

Buy 10 and get 10% Discount

524 in stock

Description

GDF-8 Myostatin 1mg Peptide Vial Austria

This product is intended for research purposes only. To be used by trained professionals only.

GDF-8, Myostatin is a myokine. Myokine’s a protein realised and produced by myocytes. These myocytes work on your muscle cells to inhibit myogenesis. Austria Studies have shown this process leads to muscle growth. Myostatin (GDF-8) is present in the muscle healing process. Its nature is inhibiting myogenesis, which is the formation of muscular tissue. Especially during embryonic development [1]. Myostatin inhibitors improve the repair of wounds including deep penetrant injuries to your bones and muscles [2].

According to Austria research, mice heterozygous for myostatin display a significant increase in muscle mass, implying that the inhibition or mutation of myostatin can lead to a marked increase in muscle development and strength [3]. Furthermore, myostatin loss-of-function can lead to a doubling of skeletal muscle mass [4].

The role of myostatin isn’t limited to muscle growth regulation. Studies have shown that myostatin deficiency can impact bone architecture and disc degeneration in the lumbar spine of mice. Notably, myostatin-deficient mice exhibit changes in craniofacial morphology, suggesting its influence extends to skeletal form [5].

Furthermore, GDF-8 has been found to be expressed in the ovaries and play a role in many ovarian processes. In addition, Austria study results show GDF-8 can shed light on the mechanisms that lead to aromatase expression, which could lead to the development of new treatment options for Ovarian Hyperstimulation Syndrome (OHSS) patients [6].


References:

[1] https://www.ncbi.nlm.nih.gov/ pubmed/20173658

[2] https://www.ncbi.nlm.nih.gov/ pubmed/20190380

[3] https://onlinelibrary.wiley.com/ doi/abs/10.1016/S0736-0266(03)00105-0

[4] https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC3753581/

[5] https://anatomypubs.onlinelibrary. wiley.com/doi/full/10.1002/ar.21024

[6] https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC8241723/


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Austria Direct Peptides website: https://austria.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.


BUY GDF-8 Myostatin Peptide Vial ONLINE today From Austria Direct Peptides

You may also like…